Robert A Henderson

Title: Innovations of Robert A Henderson in Cancer and Infectious Disease Treatment.

Introduction

Robert A Henderson is a notable inventor based in Seattle, WA (US), recognized for his contributions to the field of pharmaceutical compositions aimed at treating cancer and infectious diseases. With a total of 4 patents, Henderson has made significant strides in developing innovative methods that leverage stress protein complexes for therapeutic purposes.

Latest Patents

Henderson's latest patents focus on stress protein compositions and methods for the prevention and treatment of cancer and infectious diseases. These pharmaceutical compositions comprise a stress protein complex, which includes hsp110 or grp170 polypeptides complexed with immunogenic polypeptides. The immunogenic polypeptides are associated with various cancers or infectious diseases, such as gp100 and her2/neu ECD-PD. The compositions are designed to inhibit tumor growth and the development of cancer, as well as to provide methods for treating or preventing infectious diseases. Furthermore, the invention outlines a method for producing T cells directed against tumor or infected cells, enhancing the potential for targeted therapies.

Career Highlights

Henderson is affiliated with Health Research, Inc., where he continues to advance his research and innovations. His work has been pivotal in the development of new therapeutic strategies that utilize the body's immune response to combat diseases.

Collaborations

Some of his notable coworkers include John R Subjeck and Elizabeth A Repasky, who have collaborated with him on various research initiatives.

Conclusion

Robert A Henderson's innovative work in the field of stress protein compositions represents a significant advancement in the treatment of cancer and infectious diseases. His contributions continue to pave the way for new therapeutic approaches that harness the power of the immune system.